Deadline: 23-Apr-25
Pfizer is requesting proposals to support projects to improve healthcare in patients presenting with lower respiratory tract infection.
This RFP seeks proposals that focus on improving performance in the management of lower respiratory tract infection patients by healthcare professionals.
Area of Interest
- Potential applicants are encouraged to identify the problems, issues, barriers, and gaps in healthcare of patients with lower respiratory tract infection (LRTI), providing approaches to improve patient care, treatment and prevention, putting them in place, and measuring the outcomes of the proposed solutions
Funding Information
- Total amount of $100,000 USD will be funded.
- Project length: 1-year
Target Audience
- Pediatricians, Primary Care Physicians, Urgent Care, Family Medicine, Internal Medicine, Pulmonology, Infectious Disease Specialists
- Infants, focused on 0-1 year of age
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer International LLC. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer International LLC may be subject to rescission.
For more information, visit Pfizer.